Pharmacological characterization of 3-azabicyclo[3,2,1] octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel ETA receptor-selective antagonist-Reference-Cited by-同舟云学术

Pharmacological characterization of 3-azabicyclo[3,2,1] octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel ETA receptor-selective antagonist

Published:2008-10 Issue:5 Volume:21 Page:780-787
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Li Xin,Liu Ke-Liang,Zheng Jian-Quan,Chi Mu-Gen,Dong Jun-Jun,Dong Si-Jian,Gong Ze-Hui

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference32 articles.

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells;Yanagisawa;Nature,1988

2. Endothelin receptor blockers in cardiovascular disease;Rich;Circulation,2003

3. Endothelin receptor antagonists in pulmonary arterial hypertension;Channick;J Am Coll Cardiol,2004

4. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?;Stewart;Ann Intern Med,1991

5. Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study;Van Beneden;J Cardiac Failure,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Update on Synthetic Aspects of Bosentan Derivatives;Mini-Reviews in Medicinal Chemistry;2022-05-10

2. Miniaturized peptidomimetics and nano-vesiculation in endothelin types through probable nano-disk formation and structure property relationships of endothelins’ fragments;Nanotechnology Reviews;2021-12-24

3. Phenylalanine induces pulmonary hypertension through calcium-sensing receptor activation;American Journal of Physiology-Lung Cellular and Molecular Physiology;2020-12-01

4. Risk factors for hypertensive retinopathy in a Chinese population with hypertension: The Beijing Eye study;Experimental and Therapeutic Medicine;2018-11-14

5. The principal pathways involved in thein vivomodulation of hypoxic pulmonary vasoconstriction, pulmonary arterial remodelling and pulmonary hypertension;Acta Physiologica;2016-07-31